Nolte H, DuBuske L M
Reference Laboratory, Copenhagen, Denmark.
Ann Allergy Asthma Immunol. 1997 Jul;79(1):27-34. doi: 10.1016/S1081-1206(10)63080-3.
Measurement of allergen-specific IgE may assist in the diagnosis of allergy in selected patients. The development of new assays for determination of allergen-specific IgE should be optimized with respect to analytical sensitivity, precision, automation, and reporting of test results in mass units.
The objectives of this study were to evaluate the analytical performance of the new automated HYTEC method for the measurement of allergen-specific IgE and to compare the performance of this new assay to that of the Pharmacia CAP system.
To demonstrate parallelism, allergen-specific IgE dilution curves were generated by diluting four patient sera containing cat (19.8 kU/L), D. pteronyssinus (5.4 kU/L), birch pollen (2.6 kU/L), and timothy grass (1.0 kU/L) with equine serum. The precision study utilized sera from three different atopic donors with low levels (0.62 +/- 0.05 kU/L), moderate levels (1.45 +/- 0.18 kU/L), and high levels (13.59 +/- 0.89 kU/L) of allergen-specific IgE to three common inhalant allergens: D. pteronyssinus, timothy grass, and birch. Sera for outcome probability determinations were obtained from 54 patients who were evaluated for the presence of inhalant allergy by skin prick test and physical examination. Only sera from patients with at least one positive skin prick test that clinically correlate with the physician's evaluation of case history and physical examination were selected for study material. In this study, sensitivity and specificity are conditional probabilities describing performances of the CAP system and the HYTEC system to skin prick testing. The lowest threshold, 0.35 kU/L, recommended for detection of allergen-specific IgE was used for both systems.
The HYTEC system accurately detected a reduction in allergen-specific IgE antibody with different serum concentrations of allergen-specific IgE ranging from 0.10 kU/L to 20 kU/L. The median interdilutional coefficient of variation of 12.5% was obtained with assay samples containing 19.8 to 0.1 kU/L allergen-specific IgE antibody. During a 20-day trial period, three standard allergen-specific IgE controls, 0.62, 1.45 and 13.39 kU/L, respectively, demonstrated a mean coefficient of variation less than 18%. In 20% of the patients, duplicate assay determinations of allergen-specific IgE measurements resulted in a one-class discrepancy in the lowest assay range, 0.35 to 0.70 kU/L, only. The correlation coefficient between the HYTEC and CAP allergen-specific IgE assays was 0.77, rank correlation coefficients, being allergen-dependent and ranging from 0.62 to 0.91. Allergen-specific IgE assay sensitivity of the HYTEC system ranged from 0.78 to 1.00, whereas the assay sensitivity for the CAP system ranged from 0.50 to 1.00. Assay specificity ranged from 0.66 to 0.93 for the HYTEC system and from 0.70 to 0.87 for the CAP system. Eighty-nine percent of HYTEC-positive patients had a positive skin prick test (3% standard error) and 87% of CAP-positive patients had a positive skin prick test (4% standard error). Ninety-two percent of HYTEC-negative patients had a negative skin prick test (4% standard error), whereas 76% of CAP-negative patients had a negative skin prick test (5% standard error).
The HYTEC system fulfills the current analytical requirements necessary to measure allergen-specific IgE antibody quantitatively and qualitatively, and compares favorably in performance with the CAP system.
测定变应原特异性IgE有助于某些患者的过敏症诊断。新型变应原特异性IgE检测方法的开发应在分析灵敏度、精密度、自动化以及以质量单位报告检测结果等方面进行优化。
本研究的目的是评估新型自动化HYTEC方法测定变应原特异性IgE的分析性能,并将该新检测方法的性能与Pharmacia CAP系统的性能进行比较。
为证明平行性,用马血清稀释四份分别含有猫(19.8 kU/L)、屋尘螨(5.4 kU/L)、桦树花粉(2.6 kU/L)和梯牧草(1.0 kU/L)变应原特异性IgE的患者血清,生成变应原特异性IgE稀释曲线。精密度研究使用来自三名不同特应性供体的血清,其针对三种常见吸入性变应原(屋尘螨、梯牧草和桦树)的变应原特异性IgE水平分别为低水平(0.62±0.05 kU/L)、中等水平(1.45±0.18 kU/L)和高水平(13.59±0.89 kU/L)。用于结果概率测定的血清取自54例经皮肤点刺试验和体格检查评估是否存在吸入性过敏的患者。仅选择那些至少有一次与医生对病史和体格检查的评估临床相关的阳性皮肤点刺试验患者的血清作为研究材料。在本研究中,灵敏度和特异性是描述CAP系统和HYTEC系统相对于皮肤点刺试验性能的条件概率。两个系统均使用推荐用于检测变应原特异性IgE的最低阈值0.35 kU/L。
HYTEC系统准确检测到变应原特异性IgE抗体随血清中变应原特异性IgE浓度从0.10 kU/L到20 kU/L的降低。含有19.8至0.1 kU/L变应原特异性IgE抗体的检测样品的平均批内变异系数为12.5%。在20天的试验期内,三个标准变应原特异性IgE对照品,分别为0.62、1.45和13.39 kU/L,显示平均变异系数小于18%。在20%的患者中,变应原特异性IgE测量的重复检测仅在最低检测范围内(0.35至0.70 kU/L)出现一级差异。HYTEC和CAP变应原特异性IgE检测之间的相关系数为0.77,等级相关系数因变应原而异,范围为0.62至0.91。HYTEC系统的变应原特异性IgE检测灵敏度范围为0.78至1.00,而CAP系统的检测灵敏度范围为0.50至1.00。HYTEC系统的检测特异性范围为0.66至0.93,CAP系统的检测特异性范围为0.70至0.87。89%的HYTEC阳性患者皮肤点刺试验呈阳性(标准误差为±3%);87%的CAP阳性患者皮肤点刺试验呈阳性(标准误差为±4%)。92%的HYTEC阴性患者皮肤点刺试验呈阴性(标准误差为±4%),而76%的CAP阴性患者皮肤点刺试验呈阴性(标准误差为±5%)。
HYTEC系统满足定量和定性测定变应原特异性IgE抗体所需的当前分析要求,并且在性能上与CAP系统相比具有优势。